ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE backs PredictImmune's IBD prognosis test pharmatimes
April 02, 2019PredictImmune has announced that the National Institute for Health and Care Excellence (NICE) has published a Medtech Innovation Briefing (MIB) on the use of its PredictSURE IBD technology, for the prognosis of inflammatory bowel disease.
Pharma Sources Insight January 2025
